# BREXPIPRAZOLE
> **ANDA213782** · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2023-11-28
## Drug
- **FDA Application Number:** ANDA213782
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BREXPIPRAZOLE
- **Generic name:** Brexpiprazole
- **Active ingredients:** BREXPIPRAZOLE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ALKEM LABS LTD
- **First approval:** 2023-11-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213782)
---
*MORVS · CC0 1.0*